Abingdon Health Plc (LON:ABDX – Get Free Report) shares rose 0.8% on Thursday. The company traded as high as GBX 11 and last traded at GBX 10.84. Approximately 109,810 shares traded hands during mid-day trading, a decline of 53% from the average session volume of 235,236 shares. The stock had previously closed at GBX 10.75.
Abingdon Health Price Performance
The company’s fifty day moving average price is GBX 10.76 and its two-hundred day moving average price is GBX 10.46. The company has a quick ratio of 1.96, a current ratio of 1.91 and a debt-to-equity ratio of 15.05. The company has a market cap of £27.40 million, a price-to-earnings ratio of -13.38 and a beta of 0.13.
Abingdon Health Company Profile
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.
Further Reading
- Five stocks we like better than Abingdon Health
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
